Press Release, Munich, DE | August 2024
Acceleration of Bioprocess Development: IRUBIS secures Pre-Series A Funding led by BioProcess360 Partners
Biotech startup IRUBIS, developing a state-of-the-art real-time bioprocess monitoring solution, has successfully closed a pre-series A funding round. The financing round was led by BioProcess360 Partners, with participation from previous investors such as High Tech Gründerfonds (HTGF), Verve Ventures, Ventura BioMed Investors, RoBet KG as well as new and existing business angels from the industry as Dr. Matthias Arnold and Dr. Christoph Bremus.
Press Release, Munich, DE | October 2022
Real-Time Monitoring of Bioprocesses: IRUBIS closes EUR 2.8m seed round led by HTGF, Verve Ventures and Ventura BioMed Investors
Biotech startup IRUBIS, has raised EUR 2.8m in a seed financing round. The round was led by High-Tech Gründerfonds (HTGF), Verve Ventures and Ventura BioMed Investors with the participation of EIC Fund, the Initiative for Industrial Innovators and a number of business angels from the biotech industry or Munich startup scene.
Press Release, Munich, March 2022
IRUBIS receives 500k € as convertible loan from the EIC Fund, the equity instrument of the “EIC Accelerator Pilot”, under Horizon 2020 program.
Established in June 2020, the European Innovation Council Fund is a breakthrough initiative of the European Commission to make direct equity and quasi-equity investments in European high impact and deep tech start-ups and scale ups.
Article, published in Photonics Views, Volume 18 Issue 1
MIR Spectroscopy for Continuous Control and Monitoring of Metabolites
Source: Wiley Online Library
Article, published in CHEManager International March 2020
Glucose Control of Bioprocesses
Source: www.chemanager.com/en
Press Release, Munich, May 2020
IRUBIS receives €1.3 million from the HORIZON 2020 Program EIC Accelerator Pilot
The Munich-based start-up IRUBIS will receive €1.3 million in funding from the European Union’s Horizon 2020 research and innovation programme.
Horizon 2020 is the biggest EU Research and Innovation programme ever with nearly €80 billion of funding available over 7 years (2014 to 2020) – in addition to the private investment that this money will attract. It promises more breakthroughs, discoveries and world-firsts by taking great ideas from the lab to the market.
Spectroscopy Solutions for Materials Analysis, 2018 (p. 52)
Automated ATR for High-Throughput Laboratories
New innovations in ATR elements in conjunction with an automated
optical platform has made automated ATR measurements possible.
Using the AutoATR, spectral results are more sensitive than a typical
single reflection ATR.
International Labmate Ltd, 2018
An Innovative Breakthrough in Automated ATR Sampling
Automating spectroscopic sampling delivers benefits to chemists and laboratory technicians by speeding the development of routine calibrations, reducing monotonous tasks and increasing efficiency and output. Read more about the benefits of AutoATR in this article.
Media Downloads
Monipa Photo
IRUBIS Logo
